ADMP Adamis Pharmaceuticals Corporation

1.9
-0.02  -1%
Previous Close 1.92
Open 1.92
Price To Book 1.92
Market Cap 89853580
Shares 47,291,358
Volume 104,018
Short Ratio
Av. Daily Volume 405,583

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued March 27 2015. CRL issued again June 6, 2016. Approval announced June 15, 2017 following third submission.
Epinephrine Pre-filled Syringe (PFS)
Emergency treatment of anaphylaxis.
Phase 3 planned for December 2018.
APC-1000
Asthma/COPD
FDA Approval announced September 27, 2018.
Symjepi - low dose
Anaphylaxis
PDUFA date October 31, 2019.
Higher Dose Naloxone Injection
Opioid overdose
Refusal to file letter received February 26, 2019.
APC-8000 (sublingual tadalafil)
Erectile dysfunction

Latest News

  1. Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business Update
  2. The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA
  3. Adamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection Product Candidate
  4. Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
  5. Before You Buy Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Consider Its Volatility
  6. The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings
  7. Adamis Provides Regulatory Update on Sublingual Tadalafil
  8. Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid Epidemic
  9. Is Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Excessively Paying Its CEO?
  10. The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US
  11. Today's Research Reports on Trending Tickers: Adamis Pharmaceuticals and Biocept
  12. Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the US
  13. Detailed Research: Economic Perspectives on Biohaven Pharmaceutical Holding, Air Transport Services Group, Pattern Energy Group, First Solar, Limelight Networks, and Adamis Pharmaceuticals — What Drives Growth in Today's Competitive Landscape
  14. Adamis Has 'Favorable' Pipeline Setup, Says Bullish Raymond James
  15. Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe
  16. 4 Pharma Stocks Gaining Speed on Monday (12/31/18)
  17. Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
  18. Adamis Pharmaceuticals (ADMP) Jumps: Stock Rises 5.3%
  19. Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options